T Cell Lymphoma Survival Rate: Brief Look At The Broad Groups

It is nearly impossible to talk about a survival rate for T cell lymphomas because there are so many subtypes and varied prognoses. Thus, in addressing the T cell lymphoma survival rate, we will take a brief look at the broad groups of T cell lymphomas: Those that affect the T cells within the body (peripheral) and those that affect the T cells but originate in the skin (cutaneous).

Peripheral T Cell Lymphoma Survival Rate

Peripheral T cell lymphoma (PTCL) refers to a handful of T cell lymphoma subtypes that originate in the T cells of the lymphatic system. They represent anywhere from 10-15% of all lymphoid cancers.

With the exception of anaplastic large T cell lymphoma (ALCL), most PTCLs have an aggressive clinical course and a rather poor prognosis. Such subtypes include T cell prolymphocytic leukemia (T-PLL) and adult T cell leukemia lymphoma (ATLL), both of which can often lead to death within months of diagnosis.

However, it should be noted that these two diseases are extremely rare, especially in the United States. In the case of ALCL, this disease has been divided into two further types, ALCL ALK+ and ALCL ALK- (a pathologist must determine which subtype each patient has). Patients with ALCL ALK+ have a much better prognosis and tend to respond to first line therapy, with a 5-year survival rate of as high as 91% in some cases. Patients with ALCL ALK- however do not have as encouraging a prognosis, with a survival rate of less than half of that reported in ALK+ patients.

Natural Killer / T cell lymphomas are PTCLs that have a notoriously aggressive clinical course, and they are associated with a very poor prognosis. In some instances the survival rate from this type of T cell lymphoma is measured in months, not years.

Cutaneous T Cell Lymphoma Survival Rate

T cell lymphomas that originate in the skin, known as primary cutaneous T cell lymphomas, tend to have a higher survival rate and better prognosis than other T cell lymphomas.

In mycosis fungoides, the most common CTCL, the survival rate has been found to be highly dependent upon when the disease is discovered. For early-stage disease, 5-year survival rates can be as high as 97%, while for the most advanced stage of disease, including the stage 4 T Cell Lymphoma survival rate, that rate drops to 41%.

In the second most common CTCL, known as primary cutaneous CD30+ large cell lymphoma (PCLCL), patients can look forward to an excellent prognosis, with 5-year survival rates landing somewhere between 80-90%.

In Conclusion

In conclusion it should be clear to the reader that the T cell lymphoma survival rate varies widely because the term 'T cell lymphoma' itself refers to so many different subtypes of lymphoma with so many different outcomes. Determining the subtype is crucial in ascertaining the survival rate for a specific T cell lymphoma.

Sources

Sources: Dearden CE et al. Peripheral T cell lymphomas: diagnosis and management. Hematol Oncol Clin N Am 17(2003); 1351-1366, Demierre M et al. Prognosis, clinical outcomes and quality of life issues in cutaneous T cell lymphoma. Hematol Oncol Clin N Am, 17(2003) 1485-1507
Photo: Pexels

More Articles

More Articles

This entry looks at Non Hodgkin's Lymphoma in the lungs, clinically known as pulmonary lymphoma, one of the subtypes of lymphoma. 'Lymphoma' is an...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

The Erythrocyte Sedimentation Rate (ESR - sometimes called sed rate or sedimentation rate) is a nonspecific screening test for various...

Blood counts can be used to identify disease and monitor patient health during cancer treatments. Though these tests cannot diagnose lymphoma on...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...